Fennec Pharmaceuticals (FENC) Prepaid Assets (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Prepaid Assets came in at $1.7 million in Q4 2025, down 43.8% YoY from $3.1 million in Q4 2024, and up 23.73% on a QoQ basis from $1.4 million in Q3 2025.
Analysis
Fennec Pharmaceuticals (FENC) Prepaid Assets (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Prepaid Assets data on file, last reported at $1.7 million in Q4 2025.
- Quarterly Prepaid Assets fell 43.8% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 43.8% YoY) and the FY2025 annual result came in at $1.7 million, down 43.8% from the prior year.
- Prepaid Assets climbed to $1.7 million in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.1 million in Q4 2024 to a low of $32000.0 in Q1 2023.
- A 5-year average of $1.0 million and a median of $867500.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 30850.0% — and 2023, when it plunged 95.52%.
- Tracing FENC's Prepaid Assets over 5 years: stood at $1.0 million in 2021, then slipped by 25.53% to $770000.0 in 2022, then surged by 234.42% to $2.6 million in 2023, then grew by 19.61% to $3.1 million in 2024, then plunged by 43.8% to $1.7 million in 2025.
- The last three Prepaid Assets figures came in at $1.7 million (Q4 2025), $1.4 million (Q3 2025), and $965000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.64 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 2.58 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 639,000.00 |
| Dec 31, 2022 | 770,000.00 |
| Sep 30, 2022 | 278,000.00 |
| Jun 30, 2022 | 490,000.00 |
| Mar 31, 2022 | 715,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 409,000.00 |